Ann: VivaGel BV US FDA Appeal Outcome, page-58

@sarge17 l looked up your reference and yes there obviously is a current blackout in place according to the rules so even though there will be no market sensitive information released in the report (as l have already signaled) it is perception that is the issue.

It went on to say that after the release of such a report that generally opens a window of opportunity for on market purchases.

According to our Chairman this director has been champing at the bit to buy shares so let's see what happens within the next month.

Does anyone know how long a director has to disclose purchase details to the market?

I still do not believe for a minute that this director (Basser l think) has been unable to buy shares for almost 12 months.

Of course when they release market sensitive announcements such as the one where they provided Viraleze to the Harlequins a two bob rugby team in the UK who knows ?

Someone should write a book about this mob